Back to Search Start Over

Zinc(II)—The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19?

Authors :
Aleksandra Hecel
Małgorzata Ostrowska
Kamila Stokowa-Sołtys
Joanna Wątły
Dorota Dudek
Adriana Miller
Sławomir Potocki
Agnieszka Matera-Witkiewicz
Alicia Dominguez-Martin
Henryk Kozłowski
Magdalena Rowińska-Żyrek
Source :
Pharmaceuticals, Vol 13, Iss 9, p 228 (2020)
Publication Year :
2020
Publisher :
MDPI AG, 2020.

Abstract

Zn(II) is an inhibitor of SARS-CoV-2′s RNA-dependent RNA polymerase, and chloroquine and hydroxychloroquine are Zn(II) ionophores–this statement gives a curious mind a lot to think about. We show results of the first clinical trials on chloroquine (CQ) and hydroxychloroquine (HCQ) in the treatment of COVID-19, as well as earlier reports on the anticoronaviral properties of these two compounds and of Zn(II) itself. Other FDA-approved Zn(II) ionophores are given a decent amount of attention and are thought of as possible COVID-19 therapeutics.

Details

Language :
English
ISSN :
14248247
Volume :
13
Issue :
9
Database :
Directory of Open Access Journals
Journal :
Pharmaceuticals
Publication Type :
Academic Journal
Accession number :
edsdoj.9bf128aa1d5842bfb46cd1befcd105db
Document Type :
article
Full Text :
https://doi.org/10.3390/ph13090228